Why is Supriya Lifesci. falling/rising?

As of 03-Jul, Supriya Lifescience Ltd is currently priced at 724.00, reflecting a slight increase of 0.15 (0.02%). The stock has been on an upward trend, gaining for the last six consecutive days and achieving a total return of 7.55% during this period. Despite this positive momentum, the stock has underperformed its sector by 0.46% today. Over the past week, it has outperformed the benchmark Sensex, with a return of 6.76% compared to the Sensex's decline of 0.62%. The company has demonstrated strong financial performance, with a high return on equity of 16.77% and a low debt-to-equity ratio, alongside positive results for the last six quarters, including significant growth in net sales.
In the broader market context, while Supriya Lifescience's short-term performance has been strong, its year-to-date return of -2.14% contrasts with the Sensex's gain of 6.53%. This indicates that while the stock has recently gained traction, it has struggled to keep pace with the overall market performance in the longer term. The falling investor participation, as evidenced by a decrease in delivery volume, suggests some caution among investors despite the stock's recent gains. Overall, the combination of strong management efficiency and recent positive financial results supports the stock's upward movement, even as it faces challenges in broader market comparisons.